RBC Europe’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$8K Hold
1,118
﹤0.01% 528
2022
Q1
$9K Buy
+1,118
New +$10.1K ﹤0.01% 541

Other funds holding AMYT

RBC Europe's AMYT Position: Q2 2022 in Review

RBC Europe held its Amryt Pharma plc American Depositary Shares (AMYT) position steady in Q2 2022 at 1,118 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #528.

RBC Europe first reported a position in AMYT in Q1 2022 and has held it in 2 quarters since. The position peaked at $9K in Q1 2022. 64 funds tracked by Wall St. Rank hold AMYT as of Q2 2022.

  • RBC Europe held 1,118 shares of Amryt Pharma plc American Depositary Shares worth $8K as of Q2 2022.
  • RBC Europe left its Amryt Pharma plc American Depositary Shares share count unchanged in Q2 2022.
  • Amryt Pharma plc American Depositary Shares made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #528 holding.
  • RBC Europe first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2022 and has held it in 2 quarters since.
  • RBC Europe's Amryt Pharma plc American Depositary Shares position peaked at $9K in Q1 2022.
  • 64 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.